Ortho Regenerative Technologies Inc (CSE:ORTH) CEO Philippe Deschamps joined Proactive's Stephen Gunnion with details of the change in the company's to ChitogenX Inc, which he said better reflects its expanded clinical and commercial opportunities, mission, values, and core competencies.
Deschamps confirmed that the company's shares are expected to begin trading on the Canadian Stock Exchange under the new name and new ticker symbol 'CHGX' at market open on or around September 12, 2022.